The FDA has granted approval for Lipfendra, the first oral PCSK9 inhibitor designed to treat high cholesterol, particularly familial hypercholesterolemia. This new medication offers a non-invasive option for patients and is intended to be used alongside dietary changes and exerc…
The FDA has approved Lipfendra (enlicitide), marking the first oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor for adults with high cholesterol. This approval…
The FDA has approved Lipfendra (enlicitide), the first oral therapy to inhibit PCSK9, aimed at reducing low-density lipoprotein cholesterol (LDL-C) in adults with high cholesterol…
Researchers have developed a genomic-led framework that aims to predict adverse drug reactions (ADRs) in drug development. This approach utilizes large-scale genetic datasets to i…
The FDA has granted priority review to Lipfendra, the first oral medication designed to block the PCSK9 protein, which is crucial in regulating LDL cholesterol levels. This develo…
Recent viral claims suggest that statins, commonly prescribed cholesterol-lowering medications, may contribute to dementia. However, scientific evidence reviewed by DW Fact Check…
The FDA has approved Lipfendra, a groundbreaking pill from Merck designed to significantly lower cholesterol levels in patients at high risk of heart disease. This noninjectable m…
The FDA has approved Lipfendra, the first once-daily oral PCSK9 inhibitor, which can reduce LDL cholesterol levels by 56% to 60% when used alongside statins. Developed by Merck, t…
The FDA has approved setmelanotide, a new treatment for acquired hypothalamic obesity, following the results of the Phase 3 TRANSCEND clinical trial. This condition, often affecti…
As New York City faces a significant increase in cyclosporiasis cases, health officials urge residents to wash fruits and vegetables thoroughly to prevent this foodborne illness.…
A recent analysis reveals that while obesity drugs like GLP-1s can lead to significant weight loss, they often do not enhance quality of life or cardiovascular health for many pat…
A significant outbreak of cyclosporiasis has affected nearly 3,000 individuals across the United States, with 86 hospitalizations reported. The Centers for Disease Control and Pre…
A nonpartisan ethics watchdog has requested an investigation into Alicia Jackson, a high-ranking official at the Department of Health and Human Services, following allegations of…
In an ambitious move, RFK Jr. aims to ease access to unapproved peptide drugs, assuring patients they’ll receive a 'more controlled alternative' while keeping the actual safety of…
CRISPR Therapeutics has seen its stock price decline over the past year, trading significantly below Wall Street's price targets. Analysts predict potential gains, with one projec…
A Massachusetts woman is facing serious charges after allegedly performing unauthorized eyelid surgery that left her patient with permanent scars. Dingrui Wang, 34, is accused of…
A recently declassified CIA memo shows that Dr. Scott Gottlieb, a former FDA commissioner and current Pfizer board member, rejected findings from two California studies that indic…
This article discusses recent rulings from various U.S. courts, including the Fifth Circuit's dismissal of a drugmaker appeal against the Medicare drug negotiation program and the…